Please assess the completion status of the following clinical trial:

Trial Title: Clinical Trials of Autologous Cultured Adipose-derived Stem Cells (ANTG-ASC) on Complex Fistula

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* a patient who has complex perianal fistula~* a patient who is negative in pregnancy test~* a patient who has submitted a written consent~Exclusion Criteria:~* a patient who has participated in other clinical studies within 30 days before this clinical trial or has not passed 5 fold period of a half-life of other investigational drugs.~* a patient who has a history of variant Creutzfeldt Jacobs disease or related diseases~* a patient who is allergic to anesthetics, bovine derived proteins or a fibrin glue~* a patient who has an autoimmune disease~* a patient who has infectious diseases such as hepatitis B virus (HBV), hepatitis C virus (HCV) or human immunodeficiency virus (HIV)~* a patient who has sepsis or active tuberculosis~* a patient who is pregnant or breast feeding~* a patient who has inflammatory Bowel disease~* over 2cm in diameter of fistula

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Group 1 (Type: EXPERIMENTAL): Low dose group
- Group 2 (Type: EXPERIMENTAL): high dose group

Based on this trial design, predict the completion outcome and termination type (if applicable).